Study of the Natural History of Immunoblastic Lymphadenopathy and Atypical Immunoproliferative Disorders
- 1 January 1983
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 1 (4), 293-299
- https://doi.org/10.3109/07357908309063292
Abstract
Twenty-three patients, 9 with immunoblastic lymphadenopathy and 14 with atypical immunoproliferative disorders (A1PD), were studied in order to determine their clinical, radiographic, and pathologic features. Diffuse lymphadenopathy was present in all patients. Patients with immunoblastic lymphadenopathy (ILA) had an increased incidence of constitutional signs and symptoms. Radiographic findings in both groups were indistinguishable from those of malignant lymphomas. Of all the clinical characteristics examined to establish a prognostic significance, a positive history of allergies and the presence of polyclonal gammopathy were associated with a worse prognosis. Of the 22 patients treated, 15 initially received single agents and seven combination chemotherapy. The median survival of patients who received combination chemotherapy has not been reached at 38 months, while that of the patients on single agents is 10 months. Of 9 patients who achieved complete remission, 7 remain alive, while all 14 patients who failed to achieve a complete remission have already expired. Patients initially treated with combination chemotherapy tolerated treatment well and had a more favorable outcome with only three deaths (mostly secondary to tumor recurrence) in seven patients. Even though these entities are not considered malignant morphologically, their clinical behavior frequently resembles that of a lymphomatous disorder as confirmed by the short median survival of 22 months for AIPD and 24 months for ILA. Once progressive disease is documented, we recommend combination chemotherapy as initial therapy.This publication has 11 references indexed in Scilit:
- PREDNISONE IN TREATMENT OF ALLERGEN-ASSOCIATED ANGIO-IMMUNOBLASTIC LYMPHADENOPATHYThe Lancet, 1979
- Malignant lymphoma arising in angio-immunoblastic lymphadenopathyCancer, 1978
- Immunoblastic LymphadenopathyPublished by American Medical Association (AMA) ,1977
- Angioimmunoblastic Lymphadenopathy with Dysproteinemia Immunohistologic and Ultrastructural StudiesAmerican Journal of Clinical Pathology, 1976
- Angio-immunoblastic lymphadenopathyThe American Journal of Medicine, 1975
- Immunoblastic LymphadenopathyNew England Journal of Medicine, 1975
- ANGIO-IMMUNOBLASTIC LYMPHADENOPATHY WITH DYSPROTEINÆMIAThe Lancet, 1974
- ANGIO-IMMUNOBLASTIC LYMPHADENOPATHY WITH DYSPROTEINÆMIAThe Lancet, 1974
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958